Nishi SPE, et al. - Given lung cancer screening by low-dose CT (LDCT) in current or past tobacco smokers who satisfy criteria has resulted in a mortality benefit in clinical trials, and few data exist on the rates outside of clinical trials of imaging and diagnostic procedures after screening LDCT, therefore, researchers report rates in the community setting of follow-up imaging and diagnostic procedures following screening LDCT. They selected 11,520 enrollees age 55 to 80 years who received screening LDCT from January 1, 2016, to December 31, 2016, from Clinformatics Data Mart national database. In this commercially insured population, they found that imaging and rates of procedures following screening LDCT was low, in general. Among procedures, the adjusted rates for bronchoscopy, for percutaneous biopsy, for thoracoscopy, mediastinoscopy, and for thoracotomy were estimated to be 2.0%, 1.3%, 0.9%, 0.2%, and 0.4%, respectively.